Abstract - 2014 Volume.5 Issue.1

As we all know that Acquired Immuno Deficiency Syndrome is a deadly disease and observed on every 1st December. Our review enlightens the vision to focus on newer targets and details of their status in perspective with clinical trials data. The article encompasses newer targets related to disease such as attachment inhibitors, fusion inhibitors, chemokine co-receptors as well as lighting modern approaches like ethosomes, vaccines and various targeted delivery systems which have been found effective in comparison to the existing conventional targets such as Nucleoside Reverse Transcriptase Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors for existing AIDS therapy. The review paper definitely attracts the readers mind towards the newer targets which are set to accelerate in near future for a better treatment regimen.

[PDF] |